A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2009
11/12/2009	WO2009109870A3 Moisturizing hand sanitizer
11/12/2009	WO2009108828A3 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
11/12/2009	WO2009104176A3 Methods of attaching a molecule-of-interest to a microtube
11/12/2009	WO2009103901A3 Pharmaceutical composition containing an n‑phenylpyrazole derivative and glycofurol, use for the preparation of a topical veterinary medicament for combating fleas
11/12/2009	WO2009103035A3 Templated open flocs of anisotropic particles for enhanced pulmonary delivery
11/12/2009	WO2009098595A3 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
11/12/2009	WO2009098404A3 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
11/12/2009	WO2009097570A3 Intralymphatic chemotherapy drug carriers
11/12/2009	WO2009090495A3 Oil and liquid silicone foamable carriers and formulations
11/12/2009	WO2009076983A3 Improved pharmaceutical composition containing non-ergoline dopamine agonist and method for the preparation thereof
11/12/2009	WO2009076141A3 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
11/12/2009	WO2009072007A3 Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
11/12/2009	WO2009069006A3 Foam containing benzoyl peroxide
11/12/2009	WO2009044406A4 Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof
11/12/2009	WO2009043395A3 Pharmaceutical composition
11/12/2009	WO2009002521A3 Compositions of specific binding agents to hepatocyte growth factor
11/12/2009	WO2009001099A3 A pharmaceutical composition comprising polyaphron dispersion
11/12/2009	WO2008152398A3 Formulations for inhalation
11/12/2009	WO2008146104A3 Stable liquid composition of chondroitinsulfate and glucosamine
11/12/2009	WO2008138816A3 Solid composition comprising a clay such as kaolin
11/12/2009	WO2008080774A9 Rapidly dispersable, particulate film coating agent based on polyvinyl alcohol-polyether graft copolymers
11/12/2009	US20090281528 Osmotic pump apparatus and associated methods
11/12/2009	US20090281188 treating common acne, comedones, polymorphous acne, nodulocystic acne, acne conglobata or secondary acne with adapalene; sunscreen agents; antiproliferative agents
11/12/2009	US20090281153 Extended Release Tablet Formulation Containing Pramipexole or a Pharmaceutically Acceptable Salt Thereof
11/12/2009	US20090281044 Elastin digest compositions and methods utilizing same
11/12/2009	US20090281034 Microencapsulation and sustained release of biologically active polypeptides
11/12/2009	US20090280188 Asymmetric functionalizated nanoparticles and methods of use
11/12/2009	US20090280187 Oxidation-Stable Granulate Containing Unsaturated Fatty Acids
11/12/2009	US20090280186 Process for producing spherical base granule comprising easily water-soluble drug
11/12/2009	US20090280184 Pharmaceutical composition, method of preparation and methods of treating aches/pains
11/12/2009	US20090280183 Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration
11/12/2009	US20090280182 Devices for the treatment of wounds and methods and kits therefor
11/12/2009	US20090280181 Delivery of nucleic acid complexes from particles
11/12/2009	US20090280180 Collagen-based matrices with stem cells
11/12/2009	US20090280179 Resorbable Calcium Phosphate Based Biopolymer-Cross-Linked Bone Replacement Material
11/12/2009	US20090280178 Process for the Preparation of Sevelamer Hydrochloride and Formulation Thereof
11/12/2009	US20090280177 Pharmaceutical preparation for treating fibromyalgia
11/12/2009	US20090280176 Controlled release formulations of alprazolam
11/12/2009	US20090280175 Multilayer Proton Pump Inhibitor Tablets
11/12/2009	US20090280174 Solid Pharmaceutical Preparation
11/12/2009	US20090280173 Multilayer Omeprazole Tablets
11/12/2009	US20090280172 Galenic formulations of organic compounds
11/12/2009	US20090280171 Method of treatment with predictably breakable pharmaceutical tablets
11/12/2009	US20090280170 Compositions of GnRH related compounds and processes of preparation
11/12/2009	US20090280169 Compositions of peptides and processes of preparation thereof
11/12/2009	US20090280168 Chlamydia polypeptides used to prevent, treat, and diagnose Chlamydia infection; 98 KDa OMP antigen designated CPN100686 RY 54
11/12/2009	US20090280167 Enhancement of drug therapy by mirna
11/12/2009	US20090280166 Ferritin as a therapeutic target in abnormal cells
11/12/2009	US20090280165 Compounds that bind alpha5beta1 integrin and methods of use
11/12/2009	US20090280164 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
11/12/2009	US20090280163 High-Efficiency Fusogenic Vesicles, Methods of Producing Them, and Pharmaceutical Compositions Containing Them
11/12/2009	US20090280162 Layered wound dressing
11/12/2009	US20090280161 Thin Film Multilocular Structure Made of Collagen, Member for Tissue Regeneration Containing The Same, and Method for Producing The Same
11/12/2009	US20090280160 Phenylephrine pharmaceutical formulations and compositions for transmucosal absorption
11/12/2009	US20090280159 Process for manufacturing chewable dosage forms for drug delivery and products thereof
11/12/2009	US20090280151 Fabric with active principles and relevant recharging method of the active principles
11/12/2009	US20090280148 Casein nanoparticle
11/12/2009	US20090280070 Chewing gum comprising hydroxyapatite
11/12/2009	US20090280069 Proguanil to treat skin/mucosal diseases
11/12/2009	US20090280068 Polymorph of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
11/12/2009	US20090280067 Crystal form of 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride
11/12/2009	US20090280066 Methods and compounds for the treatment of mucus hypersecretion
11/12/2009	US20090280063 Novel pei-peg graft copolymer coating of iron oxide nanoparticles for inflammation imaging
11/12/2009	DE102008022520A1 Feste Arzneimittelformulierung mit verzögerter Freisetzung Solid pharmaceutical formulation with sustained release
11/12/2009	CA2723553A1 Solid pharmaceutical formulation with delayed release
11/12/2009	CA2723438A1 Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
11/12/2009	CA2723409A1 Method and apparatus for dry granulation
11/12/2009	CA2723307A1 Opioid composition for treating skin lesions
11/12/2009	CA2723192A1 Delivery of nucleic acid complexes from particles
11/12/2009	CA2722802A1 Granulate comprising escitalopram oxalate
11/12/2009	CA2721350A1 Encapsulation of biologically active agents
11/12/2009	CA2721307A1 Encapsulation of biologically active agents
11/12/2009	CA2721241A1 Encapsulation of biologically active agents
11/12/2009	CA2720493A1 High-fluidity and non-caking pulverulent crystalline maltitol composition
11/11/2009	EP2116524A1 Method for the synthesis of the sodium salt of retinoyl-cysteic acid and retinoyl-cysteine sulfinic acid
11/11/2009	EP2116297A1 Process for producing vesicle, vesicle obtained by the process, and process for producing frozen particle for use in vesicle production
11/11/2009	EP2116266A1 Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption
11/11/2009	EP2116265A2 Reduced-viscosity concentrated protein formulations
11/11/2009	EP2116264A1 Preparation for transnasal application
11/11/2009	EP2116256A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
11/11/2009	EP2116255A1 Therapeutic agent for spinal cord injury
11/11/2009	EP2116243A1 Gel composition for treating mycosis
11/11/2009	EP2116242A1 New pharmaceutical composition
11/11/2009	EP2116241A1 Pharmaceutical composition
11/11/2009	EP2116237A1 Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
11/11/2009	EP2116234A1 Pharmaceutical composition for external application and adhesive skin patch
11/11/2009	EP2116233A1 Dual component alginate
11/11/2009	EP2116232A1 Medicine containing galanthamine with controlled release
11/11/2009	EP2116231A1 Granulate comprising escitalopram oxalate
11/11/2009	EP2116230A2 Composition and dosage form comprising an amphiphilic molecule as a suspension vehicle
11/11/2009	EP2116229A1 Colloidal carrier system
11/11/2009	EP2116228A1 Novel cyclosporin analog microemulsion preconcentrates
11/11/2009	EP2116227A2 Ophthalmic compositions containing a synergistic combination of two polymers
11/11/2009	EP2115052A2 Urea foam
11/11/2009	EP2115008A1 Biodegradable material based on opened starch
11/11/2009	EP2114531A2 Punctal plugs and methods of delivering therapeutic agents
11/11/2009	EP2114476A1 Bioceramic implants having bioactive substance
11/11/2009	EP2114475A2 Biologically effective device and method for production thereof
11/11/2009	EP2114456A2 Stabilization of aqueous compositions of proteins with displacement buffers
11/11/2009	EP2114451A2 Anti-il-13 antibody formulations and uses thereof

1 ... 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 ... 2991